**The dNTP Respiratory Pathogen Panel (RPP) quickly identifies pathogens, determines what’s present, and crucially distinguishes whether the infection is viral or bacterial.
**Acute respiratory infection (ARI) is a leading cause of morbidity and mortality worldwide
Is it the flu or COVID? Both illnesses share common symptoms like fever, cough, and fatigue, making it challenging to distinguish between them based on symptoms alone. This overlap complicates diagnosis, and the situation is further complicated if there’s an undiagnosed co-infection with another respiratory pathogen, such as bacterial pneumonia, which can lead to acute respiratory distress syndrome (ARDS). The diagnosis and treatment plan can vary significantly depending on the specific infections identified, making accurate testing crucial.
Respiratory tract infections are caused by a variety of pathogens, often presenting with similar symptoms, which makes clinical diagnosis based solely on symptoms unreliable. While viruses are the most common cause, bacteria can also be responsible. Large, comprehensive panels might not be suitable for every seasonal or geographic need. Therefore, a single, customizable panel that allows for the selection of specific pathogens offers a clinically effective and cost-efficient solution for accurate diagnosis and treatment.
Multiple Pathogens, One Test: Accurately identifies a wide range of respiratory viruses and bacteria, including COVID-19, Influenza A, and Influenza B, with a single nasal swab.
Distinguishes Similar Symptoms: Helps differentiate between respiratory infections with overlapping symptoms, such as flu and COVID-19, providing clarity in diagnosis.
Reduces Misdiagnosis: By pinpointing the exact pathogen, the panel reduces the likelihood of misdiagnosis, leading to more effective treatment.
Guided Treatment: Knowing the exact pathogen informs the selection of targeted therapies, whether antiviral, antibacterial, or supportive care, leading to better patient outcomes.
Prevents Co-Infection Complications: Identifies co-infections that could lead to severe conditions like acute respiratory distress syndrome (ARDS), allowing for comprehensive treatment plans.
Virus | Bacteria |
Adenovirus | Bordetella pertussis |
Human Metapneumovirus | Bordetella parapertussis/B. bronchiseptica |
Influenza A | Bordetella holmesii |
Influenza A (subtype H1) |
|
Influenza A (subtype H3) |
|
Influenza B |
|
Parainfluenza 1 |
|
Parainfluenza 2 |
|
Parainfluenza 3 |
|
Parainfluenza 4 |
|
Rhinovirus |
|
RSV A |
|
RSV B |
|
We’re here to help! Whether you have questions, need more information, or are ready to get started, don’t hesitate to reach out.
CLIA# 31D2245011
CAP# 9314196
PFI# 9752